Allspring Global Investments Holdings LLC Has $51.44 Million Position in Option Care Health, Inc. (NASDAQ:OPCH)

Allspring Global Investments Holdings LLC lessened its stake in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 2.1% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 1,526,995 shares of the company's stock after selling 32,189 shares during the quarter. Allspring Global Investments Holdings LLC owned 0.86% of Option Care Health worth $51,444,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Financial Management Professionals Inc. bought a new stake in Option Care Health during the third quarter worth approximately $29,000. First Horizon Advisors Inc. acquired a new position in Option Care Health in the 3rd quarter valued at $37,000. Advisors Asset Management Inc. raised its holdings in Option Care Health by 121.4% in the 1st quarter. Advisors Asset Management Inc. now owns 1,337 shares of the company's stock worth $42,000 after acquiring an additional 733 shares during the period. NewEdge Advisors LLC raised its holdings in Option Care Health by 1,031.9% in the 1st quarter. NewEdge Advisors LLC now owns 1,562 shares of the company's stock worth $50,000 after acquiring an additional 1,424 shares during the period. Finally, Headlands Technologies LLC lifted its position in Option Care Health by 5,796.7% during the 3rd quarter. Headlands Technologies LLC now owns 1,769 shares of the company's stock worth $57,000 after acquiring an additional 1,739 shares during the last quarter. Hedge funds and other institutional investors own 98.05% of the company's stock.

Option Care Health Stock Performance

Shares of OPCH traded up $0.03 during trading hours on Thursday, reaching $31.41. 1,169,026 shares of the company traded hands, compared to its average volume of 1,193,406. The company has a debt-to-equity ratio of 0.74, a quick ratio of 1.33 and a current ratio of 1.77. The stock's fifty day moving average is $32.41 and its 200 day moving average is $31.67. Option Care Health, Inc. has a 1-year low of $24.23 and a 1-year high of $35.74. The stock has a market cap of $5.46 billion, a P/E ratio of 21.37, a price-to-earnings-growth ratio of 1.79 and a beta of 1.22.

Option Care Health (NASDAQ:OPCH - Get Free Report) last issued its quarterly earnings results on Thursday, February 22nd. The company reported $0.32 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.29 by $0.03. Option Care Health had a return on equity of 18.78% and a net margin of 6.21%. The firm had revenue of $1.12 billion for the quarter, compared to analyst estimates of $1.09 billion. During the same period in the previous year, the company posted $0.26 earnings per share. The company's quarterly revenue was up 9.5% compared to the same quarter last year. Equities research analysts anticipate that Option Care Health, Inc. will post 1.13 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of research firms have recently commented on OPCH. Jefferies Financial Group lifted their price objective on Option Care Health from $36.00 to $38.00 and gave the stock a "buy" rating in a research note on Monday, March 4th. Barrington Research lifted their price target on Option Care Health from $35.00 to $38.00 and gave the stock an "outperform" rating in a research report on Friday, February 23rd.

Insider Activity at Option Care Health

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. purchased 35,000 shares of the firm's stock in a transaction on Monday, February 26th. The shares were purchased at an average price of $31.55 per share, for a total transaction of $1,104,250.00. Following the completion of the purchase, the director now directly owns 269,528 shares of the company's stock, valued at $8,503,608.40. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website. 0.38% of the stock is currently owned by corporate insiders.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.